Viropharma, Inc. (VPHM) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts VPHM Hot Sheet
Price: $49.96 --0%
Financial Fact:
Cost of sales (excluding amortization of product rights): 27.48M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Cost of sales (excluding amortization of product rights): 27.48M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Viropharma, Inc. (NASDAQ: VPHM) reported Q2 non-GAAP EPS of $0.40, $0.02 better than the analyst estimate of $0.38. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $130.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- CollPlant (CLGN) Misses Q2 EPS by 165c
- Accenture (ACN) Tops Q4 EPS by 10c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
